AVNT vs FUL

Avient Corporation exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. While profitability metrics and recent earnings surprises are positive, declining revenue and earnings growth, coupled with a high payout ratio and elevated valuation, constrain long-term appeal. The stock trades above both the Graham Number ($26.67) and intrinsic value estimate ($8.54), suggesting overvaluation on defensive and growth criteria. However, strong short-term price momentum and analyst consensus of 'strong_buy' provide counterbalancing support.

H.B. Fuller exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. While the current price of $62.83 sits above the Graham Number ($49.65), it remains well below the growth-based intrinsic value of $85.26. The company is experiencing a divergence between declining revenue (-2.30%) and surging earnings growth (58.30%), suggesting significant margin expansion or cost optimization. Despite a bearish technical trend, the attractive forward P/E of 12.22 and analyst buy ratings support a positive outlook.